Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)

SHE:301111 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	341.92	143.14	159.1	131.11	179.21	485.35
Short-Term Investments	23.55	29.29	128.25	141.14	190.97	20.42
Trading Asset Securities	46.26	77.59	34.81	72.86	81.32	48.04
Cash & Short-Term Investments	411.73	250.01	322.16	345.11	451.51	553.81
Cash Growth	21.14%	-22.39%	-6.65%	-23.57%	-18.47%	312.00%
Accounts Receivable	109.35	97.42	85.23	74	71.01	97.57
Other Receivables	3.29	2.92	2.69	3.34	2.01	1.94
Receivables	112.64	100.35	87.91	77.34	73.02	99.51
Inventory	88.55	77.31	90.13	83.43	70.69	51.91
Prepaid Expenses	-	-	0	-	-	-
Other Current Assets	122.95	273.23	14.99	3.78	5.73	3.62
Total Current Assets	735.87	700.9	515.2	509.66	600.95	708.84
Property, Plant & Equipment	85.33	83.51	115.24	58.59	55.94	74.55
Long-Term Investments	28.75	42.5	219.41	238.08	181.28	33.47
Goodwill	7.32	7.32	7.32	-	-	-
Other Intangible Assets	28.78	29.52	29.88	30.18	7.83	7.89
Long-Term Deferred Tax Assets	11.76	13.81	13.91	8.51	8.52	1.22
Long-Term Deferred Charges	15.34	15.79	28.71	0.4	-	-
Other Long-Term Assets	2.87	0.76	3.49	10.13	2.56	0.23
Total Assets	916.02	894.13	933.17	855.54	857.07	826.2

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	73	63.72	56	34.87	29.04	37.59
Accrued Expenses	5.26	12.19	12.71	11.4	17.25	9.38
Current Portion of Leases	6.3	5.24	1.29	3.87	0.16	0.93
Current Income Taxes Payable	2.47	0.01	1.29	0.2	9.85	5.09
Current Unearned Revenue	10.35	13.49	12.44	5.39	26.88	5.66
Other Current Liabilities	6.69	7.62	11.13	10.24	10.19	7.44
Total Current Liabilities	104.08	102.28	94.85	65.97	93.36	66.08
Long-Term Leases	36.01	40.24	70.86	10.09	-	0.16
Long-Term Unearned Revenue	0.21	0.39	0.7	1.28	5.04	7.45
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.66
Total Liabilities	140.3	142.91	166.42	77.33	98.39	75.34

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	160	160	160	160	160	160
Additional Paid-In Capital	405.78	405.78	406.94	406.94	406.94	406.94
Retained Earnings	179.91	184.91	197.4	209.23	191.73	183.91
Total Common Equity	745.7	750.69	764.34	776.17	758.67	750.85
Minority Interest	30.03	0.53	2.41	2.03	-0	-
Shareholders' Equity	775.72	751.22	766.75	778.21	758.67	750.85
Total Liabilities & Equity	916.02	894.13	933.17	855.54	857.07	826.2

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	42.31	45.49	72.15	13.95	0.16	1.09
Net Cash (Debt)	369.42	204.53	250.01	331.15	451.35	552.72
Net Cash Growth	40.07%	-18.19%	-24.50%	-26.63%	-18.34%	311.19%
Net Cash Per Share	2.47	1.37	1.80	2.08	2.84	4.64
Filing Date Shares Outstanding	160	160	160	160	160	160
Total Common Shares Outstanding	160	160	160	160	160	160
Working Capital	631.79	598.63	420.34	443.69	507.59	642.77
Book Value Per Share	4.66	4.69	4.78	4.85	4.74	4.69
Tangible Book Value	709.6	713.85	727.13	745.99	750.85	742.96
Tangible Book Value Per Share	4.43	4.46	4.54	4.66	4.69	4.64
Buildings	-	75.12	76.38	68.76	74.73	79.72
Machinery	-	89.54	86.7	78.07	78.59	93.14
Construction In Progress	-	-	-	0.72	0.72	-

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error